Mobile

A 16 week randomised, open labelled, 3 armed, parallel group, treat-to-target trial comparing once daily injection of SIAC 30 (B), SIAC 45 (B) and insulin glargine, all in combination with metformin i...

Update Il y a 4 ans
Reference: EUCTR2007-002476-33

A 16 week randomised, open labelled, 3 armed, parallel group, treat-to-target trial comparing once daily injection of SIAC 30 (B), SIAC 45 (B) and insulin glargine, all in combination with metformin in subjects with type 2 diabetes failing on OAD treatment

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To assess glucose control with respect to HbA_1c after 16 weeks of treatment with SIAC 30 (B) or SIAC 45 (B) QD or insulin glargine QD, all in combination with metformin, in subjects with type 2 diabetes mellitus, failing on OAD treatment.

Inclusion criteria

  • Type 2 diabetes mellitus

Links